Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

An exome-wide study of renal operational tolerance

A. Massart, R. Danger, C. Olsen, MJ. Emond, O. Viklicky, V. Jacquemin, J. Soblet, S. Duerinckx, D. Croes, C. Perazzolo, P. Hruba, D. Daneels, B. Caljon, MS. Sever, J. Pascual, M. Miglinas, Renal Tolerance Investigators, I. Pirson, L. Ghisdal, G....

. 2022 ; 9 (-) : 976248. [pub] 20230517

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009745

BACKGROUND: Renal operational tolerance is a rare and beneficial state of prolonged renal allograft function in the absence of immunosuppression. The underlying mechanisms are unknown. We hypothesized that tolerance might be driven by inherited protein coding genetic variants with large effect, at least in some patients. METHODS: We set up a European survey of over 218,000 renal transplant recipients and collected DNAs from 40 transplant recipients who maintained good allograft function without immunosuppression for at least 1 year. We performed an exome-wide association study comparing the distribution of moderate to high impact variants in 36 tolerant patients, selected for genetic homogeneity using principal component analysis, and 192 controls, using an optimal sequence-kernel association test adjusted for small samples. RESULTS: We identified rare variants of HOMER2 (3/36, FDR 0.0387), IQCH (5/36, FDR 0.0362), and LCN2 (3/36, FDR 0.102) in 10 tolerant patients vs. 0 controls. One patient carried a variant in both HOMER2 and LCN2. Furthermore, the three genes showed an identical variant in two patients each. The three genes are expressed at the primary cilium, a key structure in immune responses. CONCLUSION: Rare protein coding variants are associated with operational tolerance in a sizable portion of patients. Our findings have important implications for a better understanding of immune tolerance in transplantation and other fields of medicine.ClinicalTrials.gov, identifier: NCT05124444.

Brussels Interuniversity Genomics High Throughput Core VUB ULB Brussels Belgium

Center for Human Genetics Clinique Universitaires Saint Luc Brussels Belgium

Center for Medical Genetics Reproduction and Genetics Reproduction Genetics and Regenerative Medicine Vrije Universiteit Brussel UZ Brussel Brussels Belgium

CHU Nantes Centre d'Investigation Clinique en Biothérapie Centre de Ressources Biologiques Nantes France

CHU Nantes Nantes Université INSERM Center for Research in Transplantation and Translational Immunology CR2TI UMR 1064 ITUN Nantes France

Department of Biostatistics University of Washington Seattle WA United States

Department of Genetic Medicine and Development Faculty of Medicine Université de Geneve Geneva Switzerland

Department of Genetics Hôpital Erasme ULB Center of Human Genetics Université Libre de Bruxelles Brussels Belgium

Department of Genetics Hôpital Universitaire des Enfants Reine Fabiola ULB Center of Human Genetics Université Libre de Bruxelles Brussels Belgium

Department of Nephrology Antwerp University Hospital and Laboratory of Experimental Medicine University of Antwerp Antwerp Belgium

Department of Nephrology Hospital Centre EpiCURA Baudour Belgium

Department of Nephrology Hospital del Mar Institute Mar for Medical Research Barcelona Spain

Department of Nephrology Hospital Universitario 12 de Octubre Madrid Spain

Human Genetics Unit Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire Brussels Belgium

Interuniversity Institute of Bioinformatics in Brussels Brussels Belgium

Istanbul Tip Fakültesi Istanbul School of Medicine Internal Medicine Nephrology Istanbul Türkiye

LabEx IGO Immunotherapy Graft Oncology Nantes France

Nephrology Center Santaros Klinikos Medical Faculty Vilnius University Vilnius Lithuania

Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czechia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009745
003      
CZ-PrNML
005      
20230721095457.0
007      
ta
008      
230707s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fmed.2022.976248 $2 doi
035    __
$a (PubMed)37265662
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Massart, Annick $u Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Department of Nephrology, Antwerp University Hospital and Laboratory of Experimental Medicine, University of Antwerp, Antwerp, Belgium
245    13
$a An exome-wide study of renal operational tolerance / $c A. Massart, R. Danger, C. Olsen, MJ. Emond, O. Viklicky, V. Jacquemin, J. Soblet, S. Duerinckx, D. Croes, C. Perazzolo, P. Hruba, D. Daneels, B. Caljon, MS. Sever, J. Pascual, M. Miglinas, Renal Tolerance Investigators, I. Pirson, L. Ghisdal, G. Smits, M. Giral, D. Abramowicz, M. Abramowicz, S. Brouard
520    9_
$a BACKGROUND: Renal operational tolerance is a rare and beneficial state of prolonged renal allograft function in the absence of immunosuppression. The underlying mechanisms are unknown. We hypothesized that tolerance might be driven by inherited protein coding genetic variants with large effect, at least in some patients. METHODS: We set up a European survey of over 218,000 renal transplant recipients and collected DNAs from 40 transplant recipients who maintained good allograft function without immunosuppression for at least 1 year. We performed an exome-wide association study comparing the distribution of moderate to high impact variants in 36 tolerant patients, selected for genetic homogeneity using principal component analysis, and 192 controls, using an optimal sequence-kernel association test adjusted for small samples. RESULTS: We identified rare variants of HOMER2 (3/36, FDR 0.0387), IQCH (5/36, FDR 0.0362), and LCN2 (3/36, FDR 0.102) in 10 tolerant patients vs. 0 controls. One patient carried a variant in both HOMER2 and LCN2. Furthermore, the three genes showed an identical variant in two patients each. The three genes are expressed at the primary cilium, a key structure in immune responses. CONCLUSION: Rare protein coding variants are associated with operational tolerance in a sizable portion of patients. Our findings have important implications for a better understanding of immune tolerance in transplantation and other fields of medicine.ClinicalTrials.gov, identifier: NCT05124444.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Danger, Richard $u CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, CR2TI, UMR 1064, ITUN, Nantes, France
700    1_
$a Olsen, Catharina $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium $u Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
700    1_
$a Emond, Mary J $u Department of Biostatistics, University of Washington, Seattle, WA, United States
700    1_
$a Viklicky, Ondrej $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Jacquemin, Valérie $u Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
700    1_
$a Soblet, Julie $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium $u Department of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium
700    1_
$a Duerinckx, Sarah $u Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
700    1_
$a Croes, Didier $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium $u Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium $u Center for Human Genetics, Clinique Universitaires Saint Luc, Brussels, Belgium
700    1_
$a Perazzolo, Camille $u Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
700    1_
$a Hruba, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Daneels, Dorien $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium $u Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
700    1_
$a Caljon, Ben $u Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium $u Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
700    1_
$a Sever, Mehmet Sukru $u Istanbul Tip Fakültesi, Istanbul School of Medicine, Internal Medicine, Nephrology, Istanbul, Türkiye
700    1_
$a Pascual, Julio $u Department of Nephrology, Hospital del Mar, Institute Mar for Medical Research, Barcelona, Spain $u Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
700    1_
$a Miglinas, Marius $u Nephrology Center, Santaros Klinikos, Medical Faculty, Vilnius University, Vilnius, Lithuania
700    1_
$a Pirson, Isabelle $u Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
700    1_
$a Ghisdal, Lidia $u Department of Nephrology, Hospital Centre EpiCURA, Baudour, Belgium
700    1_
$a Smits, Guillaume $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium
700    1_
$a Giral, Magali $u CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, CR2TI, UMR 1064, ITUN, Nantes, France $u CHU Nantes, Centre d'Investigation Clinique en Biothérapie, Centre de Ressources Biologiques (CRB), Nantes, France $u LabEx IGO "Immunotherapy, Graft, Oncology", Nantes, France
700    1_
$a Abramowicz, Daniel $u Department of Nephrology, Antwerp University Hospital and Laboratory of Experimental Medicine, University of Antwerp, Antwerp, Belgium
700    1_
$a Abramowicz, Marc $u Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium $u Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium $u Department of Genetic Medicine and Development, Faculty of Medicine, Université de Geneve, Geneva, Switzerland
700    1_
$a Brouard, Sophie $u CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, CR2TI, UMR 1064, ITUN, Nantes, France $u CHU Nantes, Centre d'Investigation Clinique en Biothérapie, Centre de Ressources Biologiques (CRB), Nantes, France $u LabEx IGO "Immunotherapy, Graft, Oncology", Nantes, France
710    2_
$a Renal Tolerance Investigators
773    0_
$w MED00188756 $t Frontiers in medicine $x 2296-858X $g Roč. 9, č. - (2022), s. 976248
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37265662 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095450 $b ABA008
999    __
$a ok $b bmc $g 1958485 $s 1196009
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 9 $c - $d 976248 $e 20230517 $i 2296-858X $m Frontiers in medicine $n Front. med. $x MED00188756
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...